Biotin-Linked Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)
Référence MBS2091462-1mL
Conditionnement : 1mL
Marque : MyBiosource
Glial Fibrillary Acidic Protein (GFAP) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2091462SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2091462 is an antibody targeting GFAP. Also known as Biotin-Linked Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP). Reactive in Rat, Human, Mouse, Rabbit, Goat. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Glial Fibrillary Acidic Protein (GFAP), Polyclonal Antibody
Full Product Name
Biotin-Linked Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)
Product Gene Name
anti-GFAP antibody
Product Synonym Names
Intermediate Filament Protein
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Rat, Human, Mouse, Rabbit, Goat
Concentration
500ug/ml (lot specific)
Matching Pairs
Unconjugated Antibody: GFAP (MBS2032444)
Biotin Conjugated Antibody: GFAP (MBS2091462)
Biotin Conjugated Antibody: GFAP (MBS2091462)
Matching Pairs
Biotin Conjugated Antibody: GFAP (MBS2091462)
Immunogen: GFAP (MBS2032955)
Immunogen: GFAP (MBS2032955)
Molecular Weight
49,508 Da
OMIM
J04569 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Conjugation
Biotin
Cross Reactivity
Rat
Immunogen
GFAP (Met1~Met430)
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-GFAP antibody
Western Blot (WB), Immunohistochemistry (IHC)
Other Notes
Small volumes of anti-GFAP antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for GFAP. It may not necessarily be applicable to this product.
NCBI Official Full Name
glial fibrillary acidic protein
NCBI Official Synonym Full Names
glial fibrillary acidic protein
NCBI Official Symbol
GFAP
NCBI Official Synonym Symbols
ALXDRD
UniProt Protein Name
Glial fibrillary acidic protein
Protein Family
Glial fibrillary acidic protein
UniProt Gene Name
GFAP
UniProt Synonym Gene Names
GFAP
NCBI Protein Information
glial fibrillary acidic protein
NCBI Summary for GFAP
This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Show more UniProt Comments for GFAP
GFAP: a class-III intermediate filament protein. A cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. An additional transcript variant isoform has been described, but its full length sequence has not been determined.
Protein type: Cytoskeletal
Chromosomal Location of Human Ortholog: 17q21.31
Cellular Component: cell body; cytoplasm; cytosol; intermediate filament; intermediate filament cytoskeleton; lysosome; myelin sheath
Molecular Function: identical protein binding; integrin binding; kinase binding; protein binding; structural constituent of cytoskeleton
Biological Process: astrocyte development; Bergmann glial cell differentiation; extracellular matrix organization; intermediate filament organization; negative regulation of neuron projection development; neuron projection regeneration; positive regulation of Schwann cell proliferation; regulation of chaperone-mediated autophagy; regulation of neurotransmitter uptake; regulation of protein complex assembly; response to wounding
Disease: Alexander Disease
Show more Protein type: Cytoskeletal
Chromosomal Location of Human Ortholog: 17q21.31
Cellular Component: cell body; cytoplasm; cytosol; intermediate filament; intermediate filament cytoskeleton; lysosome; myelin sheath
Molecular Function: identical protein binding; integrin binding; kinase binding; protein binding; structural constituent of cytoskeleton
Biological Process: astrocyte development; Bergmann glial cell differentiation; extracellular matrix organization; intermediate filament organization; negative regulation of neuron projection development; neuron projection regeneration; positive regulation of Schwann cell proliferation; regulation of chaperone-mediated autophagy; regulation of neurotransmitter uptake; regulation of protein complex assembly; response to wounding
Disease: Alexander Disease
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Pathways associated with anti-GFAP antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Neural Crest Differentiation Pathway antibodies | Neural Crest Differentiation Pathway Diagram |
| Nuclear Signaling By ERBB4 Pathway antibodies | Nuclear Signaling By ERBB4 Pathway Diagram |
| Signal Transduction Pathway antibodies | Signal Transduction Pathway Diagram |
| Signaling By ERBB4 Pathway antibodies | Signaling By ERBB4 Pathway Diagram |
| Spinal Cord Injury Pathway antibodies | Spinal Cord Injury Pathway Diagram |
Diseases associated with anti-GFAP antibody
| Disease Name | Pubmed Publications |
|---|---|
| Nervous System Diseases Antibodies | >4363 publications with GFAP and Nervous System Diseases |
| Brain Diseases Antibodies | >3314 publications with GFAP and Brain Diseases |
| Gliosis Antibodies | >999 publications with GFAP and Gliosis |
| Cardiovascular Diseases Antibodies | >763 publications with GFAP and Cardiovascular Diseases |
| Brain Injuries Antibodies | >608 publications with GFAP and Brain Injuries |
| Drug Toxicity Antibodies | >538 publications with GFAP and Drug Toxicity |
| Nerve Degeneration Antibodies | >506 publications with GFAP and Nerve Degeneration |
| Inflammation Antibodies | >490 publications with GFAP and Inflammation |
| Necrosis Antibodies | >490 publications with GFAP and Necrosis |
| Epilepsy Antibodies | >325 publications with GFAP and Epilepsy |
Organs/Tissues associated with anti-GFAP antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Brain Antibodies | >7094 publications with GFAP and Brain |
| Nerve Antibodies | >3091 publications with GFAP and Nerve |
| Blood Antibodies | >1391 publications with GFAP and Blood |
| Spinal Cord Antibodies | >1207 publications with GFAP and Spinal Cord |
| Eye Antibodies | >903 publications with GFAP and Eye |
| Muscle Antibodies | >463 publications with GFAP and Muscle |
| Ganglia Antibodies | >257 publications with GFAP and Ganglia |
| Bone Marrow Antibodies | >224 publications with GFAP and Bone Marrow |
| Liver Antibodies | >183 publications with GFAP and Liver |
| Connective Tissue Antibodies | >161 publications with GFAP and Connective Tissue |


